THE new innovative BlastX is now available in Australia: BlastX acts in 3 ways to destroy bacteria, deconstruct biofilms and defend against recolonisation, plus it promotes a moist wound environment for faster healing. Dermatologists and GPs are referring patients to pharmacies for BlastX -- sold over the counter without a prescription.
Suitable for acute and chronic wounds: Post-Surgical, Partial/full thickness, Grafted & donor wounds, Pressure injuries, 1st and 2nd degree burns and Diabetic foot & leg ulcers.
Available at a 20% discount to pharmacies for a limited time.
RRP: $27.99 (7.5ml tube) and $69.99 (30ml tube)
Supplier: Symbion PDE: 7.5ml tube - 679356. 30ml tube - 677868. CH2 PDE: 7.5ml tube - 2589074. 30ml tube - 2589082.
Website: www.blastx.net.auThe above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 23 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 23
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.